Personalization of renal replacement therapy and its effect on survival of patients with stage 5 chronic kidney disease aged 60 and older

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Objective. Evaluation of the effectiveness of alternative treatment options (ATOs) for stage 5 chronic kidney disease in patients aged ≥60 years and development of algorithm for choosing ATOs.

Materials and methods. The historical control group (HCG) (237 patients) received a standard dialysis regimen, while the experimental group (EG) (62 patients) received ATOs (conservative treatment, palliative, incremental, or standard dialysis regimens).

Results. Survival on the 90th day was 73.4±3% in the HCG, 84.4±4.8% in the EG, on the 365th day: 51.4±3.4% in the HCG, 69.6±6.9% in the EG. Evaluation of the adverse outcome risk reduction showed that treatment with ATOs reduced the risk of adverse outcome by 48 (95% confidence interval 12–69)%.

Conclusion. Due to the effectiveness of ATOs, it is necessary to consider the possibility of their inclusion in clinical protocols for the treatment of patients.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Krystsina Kurylovich

1st City Clinical Hospital

Хат алмасуға жауапты Автор.
Email: khruns89@gmail.com
ORCID iD: 0000-0002-9112-4863

Nephrologist, Hemodialysis Department

Белоруссия, 64 Nezavisimosti Ave, Minsk, 220013

Kirill Komissarov

Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology

Email: kirill_ka@tut.by
ORCID iD: 0000-0002-2648-0642

Cand.Sci. (Med.), Associate Professor, Head of the Department of Nephrology

Белоруссия, 8 Semashko st., Minsk, 220087

Olga Krasko

United Institute of Informatics Problems of the National Academy of Sciences of Belarus

Email: krasko@newman.bas-net.by
ORCID iD: 0000-0002-4150-282X

Cand.Sci.(Tech.), Leading Researcher, Bioinformatics Laboratory

Белоруссия, 6 Surganov St., Minsk, 220012

Siarhei Kamisarau

16th City Children's Polyclinic, Minsk

Email: serge.kom142@gmail.com
ORCID iD: 0009-0003-2966-3780

Pediatrician

Белоруссия, 45 Odoevsky st., Minsk, 220074

Aksana Ilyinchyk

1st City Clinical Hospital

Email: i_o_v@tut.by
ORCID iD: 0009-0006-3243-9503

Nephrologist, Head of the Hemodialysis Department

Белоруссия, 64 Nezavisimosti Ave, Minsk, 220013

Siarhei Prylutski

Minsk Order of the Red Banner of Labor Regional Clinical Hospital

Email: priluckii.s@mokb.by
ORCID iD: 0009-0004-5174-1893

Nephrologist, Head of the Department of Hemodialysis with Extracorporeal Detoxification Methods

Белоруссия, Borovlyansky village council, 201 near the Lesnoy agricultural complex, Minsk district, Minsk region, 223040

Yauheni Zhaholkin

Mogilev Regional Clinical Hospital

Email: Zhagolkin69@mail.ru
ORCID iD: 0009-0003-5441-9018

Nephrologist, Head of the Hemodialysis and Nephrology Department

Белоруссия, 12 Byalynitsky-Biruli Street, Mogilev, 212026

Әдебиет тізімі

  1. Saeed F., Arrigain S., Schold J. D., et al. What are the risk factors for one-year mortality in older patients with chronic kidney disease? An analysis of the Cleveland Clinic CKD Registry. Nephron. 2019;141:98–104.
  2. Teuwafeu D.G., Mambap A.T., Alake P.A., et al. Survival in elderly patients with kidney failure starting haemodialysis in Cameroon. African J Nephrol. 2023;26:111–16.
  3. McAdams-DeMarco M.A., Daubresse M., Bae S., et al. Dementia, Alzheimer’s disease, and mortality after hemodialysis initiation. Clin J Am Soc Nephrol. 2018;13:1339–47.
  4. Chaudhary K., Sangha H., Khanna R. Peritoneal dialysis first: rationale. Clin J Am Soc Nephrol. 2011;6:447–56.
  5. Chrysohoou C., Bougatsos G., Magkas N., et al. Peritoneal dialysis as a therapeutic solution in elderly patients with cardiorenal syndrome and heart failure: A case-series report. Hellenic J Cardiol. 2020;61:73–7.
  6. Lança A., Carvalho M., Rodrigues A. Peritoneal Dialysis in the elderly: challenge accepted. Portuguese J Nephrol Hypertens. 2018;32:101–9.
  7. Blake P.G., Dong J., Davies S.J. Incremental peritoneal dialysis. Peritoneal Dial Int. 2020;40:320–6.
  8. Khatri P., Davenport A. Dialysis for older adults: why should the targets be different? J Nephrol. 2024:1–10.
  9. Couchoud C.G., Beuscart J.B.R., Aldigier J.C., et al. Development of a risk stratification algorithm to improve patient-centered care and decision making for incident elderly patients with end-stage renal disease. Kidney Int. 2015;88:1178–86.
  10. Murea M., Moossavi S., Garneata L., et al. Narrative review of incremental hemodialysis. Kidney Int Rep. 2020;5:135–48.
  11. FitzGerald T.J., Joosten H., Van Buren M., et al. A review of supportive care for older people with advanced chronic kidney disease. Clin Kidney J. 2023;16:635–46.
  12. Lu E., Chai E. Kidney supportive care in peritoneal dialysis: developing a person-centered kidney disease care plan. Kidney Med. 2022;4:100392.
  13. Tentori F., Hunt A., Nissenson A.R. Palliative dialysis: addressing the need for alternative dialysis delivery modes. Semin Dial. 2019;32:391–5.
  14. Brown E.A., Hurst H. Delivering peritoneal dialysis for the multimorbid, frail and palliative patient. Peritoneal Dial Int. 2020:0896860819893558.
  15. Hussain J.A., Mooney A., Russon L. Comparison of survival analysis and palliative care involvement in patients aged over 70 years choosing conservative management or renal replacement therapy in advanced chronic kidney disease. Palliative Med. 2013;27:829–39.
  16. Brown E.A. Maximal conservative management. Medicine. 2015;43:493–5.
  17. Калачик О.В., Пилотович В.С., Комиссаров К.С. и др. Диагностика и лечение пациентов (взрослое население) с хронической болезнью почек 5 стадии методом программного гемодиализа. ПРОФ-ПРЕСС. 2021. [Kalachik O.V., Pilotovich V.S., Komissarov K.S. Diagnosis and treatment of patients (adults) with stage 5 chronic kidney disease using hemodialysis. PROF-PRESS. 2021 (In Russ.)].
  18. Калачик О.В., Пилотович В.С., Комиссаров К.С. и др. Диагностика и лечение пациентов (взрослое население) с хронической болезнью почек 5 стадии методом перитонеального диализа. ПРОФ-ПРЕСС. 2021. [Kalachik O.V., Pilotovich V.S., Komissarov K.S. Diagnosis and treatment of patients (adults) with stage 5 chronic kidney disease using peritoneal dialysis. PROF-PRESS. 2021. (In Russ.)].
  19. Курилович К.А., Комиссаров К.С., Красько О.В. Стратификация риска летального исхода с учетом оценки старческой астении и коморбидности у пациентов в возрасте 60 лет и старше с 5-ой стадией хронической болезни почек. Неотложная кардиология и кардиоваскулярные риски. 2024;8:2113–24. [Kurylovich K.A., Komissarov K.S., Krasko O.V. Death risk stratification in patients aged 60 years and older with stage 5 chronic kidney disease using frailty assessment and comorbidity evaluation. Neotlozhn Kardiol Kardiovask Riski. 2024;8:2113–24. doi: 10.51922/2616-633X.2024.8.1.2113 (In Russ.)].
  20. Cumulative Frailty Index (FI) [Electronic resource]. Mode of access: https://www.medicalalgorithms.com/frailty-index-calculator. Date of access: 28.11.2024.
  21. Charlson M.E., Pompei P., Ales K. L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.
  22. Pálsson R., Chronic Kidney Disease Epidemiology Collaboration. New creatinine-and cystatin C–based equations to estimate GFR without race. New Engl J Med. 2021;385:1737–49.
  23. Axelsson L., Benzein E., Lindberg J., et al. End-of-life and palliative care of patients on maintenance hemodialysis treatment: a focus group study. BMC. Palliative Care. 2019;18:1–10.
  24. Kalantar-Zadeh K., Crowley S.T., Beddhu S., et al. Renal replacement therapy and incremental hemodialysis for veterans with advanced chronic kidney disease. Semin Dial. 2017;30:251–61.
  25. Mathew A., Obi Y., Rhee C. M., et al. Treatment frequency and mortality among incident hemodialysis patients in the United States comparing incremental with standard and more frequent dialysis. Kidney Int. 2016;90:1071–9.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу
2. Fig. 1. RRT option 90 days after the start of dialysis in 2-4 treatment subgroups

Жүктеу (16KB)
Метадеректер
3. Fig. 2. Cumulative survival of EG subgroups

Жүктеу (32KB)
Метадеректер
4. Fig. 3. Algorithm for choosing a treatment option in patients aged 60 years and older with CKD C5

Жүктеу (32KB)
Метадеректер